QIU, Y., FERNNDEZ-GARCA, B., LEHMANN, H.I., LI, G., KROEMER, G., LPEZ-OTN, C
It appears the drug manufacturers of G-agonists have no interest in this vital objective, without any ongoing prospective clinical trial efforts directed at cessation of their drugs without reversal of weight gain and assorted benefits
Its only substrate is hydrogen peroxide
For example, SASP reduces GSH expression levels at the cellular level, which induces growth arrest in breast cancer cells and increase the efficacy of anticancer drugs, such as doxorubicin (83), similar to preclinical investigations in vitro and in vivo (84)